UPDATE: MEDNAX Announces Data Milestone for Pediatrix Segment

MEDNAX, Inc., MD today announced that it has recorded the one million neonatal health record in its Clinical Data Warehouse (CDW) using BabySteps®, the company's proprietary and certified electronic health record (EHR). BabySteps was developed in 1996 and has since been used in Pediatrix Medical Group Neonatal Intensive Care Units (NICUs) to capture a consistent set of information about patients, which then gets entered in to the CDW. Pediatrix's CDW is now recognized as one of the world's most robust neonatal databases for both the quality and quantity of its data. It is increasingly used and quoted as a source of critical information and has been shared in collaboration with numerous academic institutions, including Duke University, Vanderbilt University and the University of Pennsylvania, as well as being queried often by health organizations such as the National Institutes of Health, the U.S. Food and Drug Administration, and the Centers for Disease Control. “Having one million neonatal records in our Clinical Data Warehouse is truly a milestone with great significance to our patients, physicians and our hospital partners,” said Alan Spitzer, M.D., Senior Vice President and Director of Clinical Research, Education and Quality at MEDNAX. “By analyzing these data, using them to develop quality-improvement initiatives, and benchmarking our outcomes, we empower our health care providers to deliver better, more cost-effective care.” In 2009, using the data garnered by BabySteps and stored in the CDW, Pediatrix launched the 100,000 Babies Campaign as the ongoing focus of the company's neonatal Clinical Quality Initiative (CQI) efforts. This ongoing multi-disciplinary program focuses on a balanced approach to improving NICU processes that drive neonatal outcomes. The 100,000 Babies Campaign has demonstrated sustained improvement in outcomes such as enhancing nutrition and weight gain in low birth-weight infants, optimizing medication use, reducing central line infections, minimizing mechanical ventilation and reducing suboptimal admission temperatures. As part of MEDNAX's ongoing commitment to improving patient care through evidence-based medicine, the Company leads and engages in clinical research, education and continuous quality improvement initiatives across its Pediatrix and American Anesthesiology Divisions. These initiatives contribute to improved patient outcomes and reduce long-term health system costs. In addition, the Company's investments in these areas help to attract and retain clinicians, improve clinical operations and enhance practice communication.